Author

Cyril Gaudin

Centre National de la Recherche ScientifiqueORCID 0009-0002-1833-1193Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alain R. BaulardiD· 2 shared Adolfo García-Pérez· 1 shared Alessia MichelottiiD· 1 shared Ana Yepes· 1 shared Astrid Lenne· 1 shared C. ReyiD· 1 shared Camille GrosseiD· 1 shared Christophe GuilhotiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Alain R. BaulardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DDU384: A new preclinical candidate for the treatment of Tuberculosis

Simon R. Green, Kirsteen I. Buchanan, Helena I. Boshoff, Paul J. Koovits, Dinakaran Murugesan, Cristina De Cozar-Gallardo, Ana Yepes, Eik Hoffmann, Lisa M. Massoudi, Paul J. Converse, Oliver D. Komm, Laura Guijarro-López, Patricia Casado, Paul Scullion, Adolfo García-Pérez, , Laura A. T. Cleghorn

This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.

bioRxiv · Oct 27, 2026 · PreprintMicrobiology

Exploiting Vitamin B6 Dependency: BVL3572S Inhibits HisC and AlaA to Kill Mycobacterium tuberculosis

Zainab Edoo, Astrid Lenne, Camille Grosse, Marie Devaere, Marion Michel, Guillaume Caron, Ernesto Anoz‐Carbonell, Kamel Djaout, Rosangela Frita, Cyril Gaudin, Line Hofmann, Sophie Lecher, Véronique Mégalizzi, Alessia Michelotti, David Rengel, , Alain R. Baulard

This paper identifies BVL3572S as a compound that inhibits HisC and AlaA in Mtb, causing metabolic stress and showing synergy with existing drugs.

Cell chemical biology · Aug 1, 2026Peer-reviewedMicrobiology